Aarti Pharmalabs Ltd

Company Profile

Aarti Pharmalabs Ltd had its IPO on under the ticker symbol AARTIPHARM.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Aarti Pharmalabs Ltd has a staff strength of 0 employees.

Stock update

Shares of Aarti Pharmalabs Ltd opened at ₹440.95 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹419.6 - ₹447.8, and closed at ₹425.65.

This is a -3.09% slip from the previous day's closing price.

A total volume of 31,564 shares were traded at the close of the day’s session.

In the last one week, shares of Aarti Pharmalabs Ltd have increased by +4.79%.

Aarti Pharmalabs Ltd's Key Ratios

Aarti Pharmalabs Ltd has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Aarti Pharmalabs Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Aarti Pharmalabs Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Aarti Pharmalabs Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q0.33333333333333, Aarti Pharmalabs Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Aarti Pharmalabs Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Aarti Pharmalabs Ltd’s profitability.

Aarti Pharmalabs Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Aarti Pharmalabs Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Aarti Pharmalabs Ltd ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

Aarti Pharmalabs Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Aarti Pharmalabs Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2024, Aarti Pharmalabs Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Aarti Pharmalabs Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹425.65

52-Week High

₹424.4

52-Week Low

₹269

Analyst Target Price

₹

Aarti Pharmalabs Ltd stock is currently trading at ₹425.65 per share. It touched a 52-week high of ₹424.4 and a 52-week low of ₹424.4. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹367.38 and 200-day moving average was ₹0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.